225 related articles for article (PubMed ID: 32118712)
21. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study.
Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H
Ann Intern Med; 2012 Jun; 156(12):841-7, W295. PubMed ID: 22711076
[TBL] [Abstract][Full Text] [Related]
22. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
[TBL] [Abstract][Full Text] [Related]
23. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
Nahon P; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Roudot-Thoraval F; Audureau E;
Gastroenterology; 2018 Nov; 155(5):1436-1450.e6. PubMed ID: 30031138
[TBL] [Abstract][Full Text] [Related]
24. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.
Kanwal F; Kramer JR; Mapakshi S; Natarajan Y; Chayanupatkul M; Richardson PA; Li L; Desiderio R; Thrift AP; Asch SM; Chu J; El-Serag HB
Gastroenterology; 2018 Dec; 155(6):1828-1837.e2. PubMed ID: 30144434
[TBL] [Abstract][Full Text] [Related]
25. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
26. The epidemiology and prevention of hepatocellular carcinoma.
Monto A; Wright TL
Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
[TBL] [Abstract][Full Text] [Related]
27. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair S; Mason A; Eason J; Loss G; Perrillo RP
Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
[TBL] [Abstract][Full Text] [Related]
28. Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis.
Rodríguez M; González-Diéguez ML; Varela M; Cadahía V; Andrés-Vizán SM; Mesa A; Castaño A; Alvarez-Navascués C
Am J Gastroenterol; 2021 Dec; 116(12):2390-2398. PubMed ID: 34569986
[TBL] [Abstract][Full Text] [Related]
29. Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.
Lim YS; Han S; Heo NY; Shim JH; Lee HC; Suh DJ
Gastroenterology; 2014 Jul; 147(1):152-61. PubMed ID: 24583062
[TBL] [Abstract][Full Text] [Related]
30. Impact of All-Oral Direct-Acting Antivirals on Clinical and Economic Outcomes in Patients With Chronic Hepatitis C in the United States.
Park H; Wang W; Henry L; Nelson DR
Hepatology; 2019 Mar; 69(3):1032-1045. PubMed ID: 30289989
[TBL] [Abstract][Full Text] [Related]
31. Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
Hwang IC; Chang J; Kim K; Park SM
Sci Rep; 2018 Mar; 8(1):4968. PubMed ID: 29563592
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus infection in alcoholic liver cirrhosis in Japan: its contribution to the development of hepatocellular carcinoma.
Miyakawa H; Sato C; Izumi N; Tazawa J; Ebata A; Hattori K; Sakai H; Ikeda T; Hirata R; Sakai Y
Alcohol Alcohol Suppl; 1993; 1A():85-90. PubMed ID: 8141927
[TBL] [Abstract][Full Text] [Related]
33. [Long-term follow-up study of alcoholic liver disease].
Kato K; Nishimura D; Sano H; Katada N; Sugimoto Y; Noba H; Yoshino M; Samori T; Mitani Y; Takeichi M
Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1829-36. PubMed ID: 2174475
[TBL] [Abstract][Full Text] [Related]
34. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
[TBL] [Abstract][Full Text] [Related]
35. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
van der Meer AJ; Feld JJ; Hofer H; Almasio PL; Calvaruso V; Fernández-Rodríguez CM; Aleman S; Ganne-Carrié N; D'Ambrosio R; Pol S; Trapero-Marugan M; Maan R; Moreno-Otero R; Mallet V; Hultcrantz R; Weiland O; Rutter K; Di Marco V; Alonso S; Bruno S; Colombo M; de Knegt RJ; Veldt BJ; Hansen BE; Janssen HLA
J Hepatol; 2017 Mar; 66(3):485-493. PubMed ID: 27780714
[TBL] [Abstract][Full Text] [Related]
36. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
37. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
Simon TG; Ma Y; Ludvigsson JF; Chong DQ; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Chung RT; Zhang X; Chan AT
JAMA Oncol; 2018 Dec; 4(12):1683-1690. PubMed ID: 30286235
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
[TBL] [Abstract][Full Text] [Related]
39. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study.
Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage C; Gunathilaka B; Jayathunge S; de Silva HJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):401-5. PubMed ID: 26256085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
